The extracellular matrix (ECM) plays an essential role in the regulation of cell proliferation during angiogenesis. Cell adhesion to ECM is mediated by binding of cell surface integrin receptors, which both activate intracellular signaling cascades and mediate tension-dependent changes in cell shape and cytoskeletal structure. Although the growth control field has focused on early integrin and growth factor signaling events, recent studies suggest that cell shape may play an equally critical role in control of cell cycle progression. Studies were carried out to determine when cell shape exerts its regulatory effects during the cell cycle and to analyze the molecular basis for shape-dependent growth control. The shape of human capillary endothelial cells was controlled by culturing cells on microfabricated substrates containing ECM-coated adhesive islands with defined shape and size on the micrometer scale or on plastic dishes coated with defined ECM molecular coating densities. Cells that were prevented from spreading in medium containing soluble growth factors exhibited normal activation of the mitogen-activated kinase (erk1/erk2) growth signaling pathway. However, in contrast to spread cells, these cells failed to progress through G1 and enter S phase. This shape-dependent block in cell cycle progression correlated with a failure to increase cyclin D1 protein levels, down-regulate the cell cycle inhibitor p27 Kip1 , and phosphorylate the retinoblastoma protein in late G1. A similar block in cell cycle progression was induced before this same shape-sensitive restriction point by disrupting the actin network using cytochalasin or by inhibiting cytoskeletal tension generation using an inhibitor of actomyosin interactions. In contrast, neither modifications of cell shape, cytoskeletal structure, nor mechanical tension had any effect on S phase entry when added at later times. These findings demonstrate that although early growth factor and integrin signaling events are required for growth, they alone are not sufficient. Subsequent cell cycle progression and, hence, cell proliferation are controlled by tension-dependent changes in cell shape and cytoskeletal structure that act by subjugating the molecular machinery that regulates the G1/S transition.
INTRODUCTION
The extracellular matrix (ECM) 1 plays a key role in angiogenesis by modulating capillary endothelial (CE) cell sensitivity to soluble mitogens and, thereby, switching cells between growth, differentiation, and involution in the local tissue microenvironment (Ingber et al., 1986; Ingber and Folkman, 1989a; Brooks et al., 1994) . Part of this switching mechanism is based on the ability of the ECM to resist cell tractional forces and thereby promote tension-dependent changes in CE cell shape (Ingber et al., 1986; Ingber and Folkman, 1989b; Ingber, 1990; Chen et al., 1997) . In fact, cell shape appears to be fundamental to growth control in all anchorage-dependent cells (Folkman and Moscona, 1978; Ben Ze'ev et al., 1980; Assoian and Zhu, 1997) and deregulation of this form of mechanical control may be involved in tumor formation (Wittelsberger et al., 1981; Ingber and Jamieson, 1985; Schwartz and Ingber, 1994) . The term cell "shape," as used here refers to the degree of cell extension or spreading, rather than any distinct form or configuration (e.g., polygonal vs. bipolar). Nevertheless, the molecular mechanism by which cell shape or mechanical (tension-dependent) distortion of cells controls their growth remains unknown.
Most work on adhesion-dependent growth control has focused on integrin signaling. Integrins represent a family of heterodimeric cell surface protein receptors that bind to ECM proteins, such as fibronectin (FN) (Ruoslahti, 1991; Hynes, 1992) . Integrins promote cell attachment and transduce biochemical signals to the nucleus by activating intracellular signaling pathways that are also used by growth factor receptors (Juliano and Haskill, 1993; Brugge, 1995, Schwartz et al., 1995) . Integrin occupation and clustering leads to stimulation of early mitogenic events associated with the G0/G1 transition, including expression of immediate early growth response genes (Schwartz et al., 1991 , McNamee et al., 1993 , Vuori and Ruoslahti, 1993 Chen et al., 1994; Dike et al., 1996) . However, these early growth signals that occur within minutes to a few hours after integrin stimulation are not sufficient to promote progression to S phase (Ingber, 1990) . Additional sustained signals later in G1, which require the integrity of the cytoskeleton and cell spreading, appear to be necessary for S phase entry and cell proliferation (Folkman and Moscona, 1978; Ben Ze'ev et al., 1980; Ingber, 1990; Ingber et al., 1995; Iwig et al., 1995; Bohmer et al., 1996; Chen et al., 1997) .
Studies using fibroblasts that exhibit anchorage-dependent growth revealed that cell adhesion regulates the transition through the cell cycle restriction point "R" late in G1 phase (Otsuka and Moskowitz, 1975; Pardee, 1989; Guadagno and Assoian, 1991; Assoian and Zhu, 1997) . Unanchored fibroblasts remain arrested in mid G1, whereas the same cells pass through this restriction point and enter S phase when allowed to reattach to a solid substrate that mediates cell attachment and spreading. This cell cycle gate in late G1 marks the end of a requirement for external growth factor stimulation and correlates with the phosphorylation of the retinoblastoma protein (pRb) by cyclindependent kinases (cdks) (Weinberg, 1995 , Sherr, 1996 . The G1/S cell cycle arrest observed in suspended fibroblasts has been attributed to increased levels of the cdk inhibitors p27 Kip1 and p21 Cip1 , which inhibit the kinase activity of cdks and prevent cell cycle progression (Sherr and Roberts, 1995; Fang et al., 1996; Schulze et al., 1996; Zhu et al., 1996) . However, other studies show that an intact cytoskeleton is required for cell adhesion to promote passage through this cell cycle checkpoint by using cytochalasin drugs that disrupt actin network continuity Iwig et al., 1995; Bohmer et al., 1996) . Thus, it is not clear whether adhesion to ECM exerts its effects on growth via direct integrin receptor signaling mechanisms or indirectly through associated integrin-dependent changes in cytoskeletal tension and associated changes in cell shape and cytoskeletal structure.
Although cell shape appears to be a physiological control element during angiogenesis (Ingber et al., 1986; Ingber and Folkman, 1989a,b) , almost nothing is known about the molecular basis of shape-dependent growth control in CE cells. In the present study, we set out to determine directly whether cell adhesion or cell deformation is the primary regulator of progression through G1 in CE cells. We also attempted to identify where cell shape acts in the cell cycle, how it exerts these growth-regulatory effects, and whether cytoskeletal tension or integrity alone is critical for this control. Cell spreading was controlled by plating cells on two different novel substrates: plastic dishes coated with different densities of FN and micrometer-sized adhesive islands that physically limit cell spreading on a saturating FN density (Chen et al., 1997) . The latter substrate allowed us to separate effects elicited by cell attachment (direct integrin engagement) from those induced by subsequent cell spreading and cytoskeletal reorganization. Using this approach, we show that attached CE cells that are prevented from spreading fail to increase cyclin D1 levels or down-regulate the cell cycle inhibitor p27
Kip1 and hence are arrested in late G1 before pRb hyperphosphorylation. Furthermore, similar results were obtained using drugs that disrupt actin microfilament continuity or inhibit cytoskeletal tension generation without altering cell shape. The results indicate that tension-dependent changes in cell shape and cytoskeletal structure act at a specific point in the cell cycle to influence integrin and growth factor signaling. They also reveal that mechanical forces, extracellular matrix, and growth factors all interplay to control G1/S progression in CE cells; however, the mechanical signal associated with cell shape changes appears to be the dominant regulator when levels of mitogens and ECM are optimal.
MATERIALS AND METHODS

Cell Culture and Reagents
Primary human pulmonary CE cells were obtained from Clonetics (San Diego, CA) and cultured for three to five passages in EBM medium (Clonetics) supplemented with 10 ng/ml human recombinant epidermal growth factor (EGF), 12 g/ml bovine brain extract, 1 g/ml hydrocortisone, and 10% FBS (all from Clonetics). Before experimental manipulation, cells were synchronized by treatment with 40 M lovastatin (Merck, Rahway, NJ) in standard culture medium for 32 h. This cell cycle arrest was released by washing the cells free of lovastatin, trypsinizing, and replating them on FNcoated adhesive substrates in experimental medium containing 4 mM mevalonate (Sigma, St. Louis, MO) prepared from the lactone form (Keyomarsi et al., 1991) . For experiments, the culture medium was modified by lowering the concentration of FBS to 2% and adding 5 ng/ml recombinant basic fibroblast growth factor (bFGF) (Takeda Chemical Industries, Osaka, Japan), 10 g/ml high-density lipoprotein (Perimmune, Rockville, MD), and 5 g/ml transferrin (Collaborative Research, Lexington, MA).
In certain experiments, cytochalasin D (cyto D, 1 g/ml; Sigma) or latrunculin B (lat B, 0.1 g/ml; Calbiochem, La Jolla, CA) was included in the medium; these doses have been shown to fully disrupt actin microfilament integrity in CE cells our unpublished results) . 2,3-Butanedione 2-monoxime (Sigma) was used at the concentration of 20 mM, which inhibits cytoskeletal tension generation and prevents the formation of focal adhesion and actin bundles in endothelial cells (Chrzanowska-Wodnicka and Burridge, 1996; Chicurel et al., 1998b) . Anti-p27
Kip1 antisense and mismatch control oligonucleotides were provided by M. Flanagan (Gilead Sciences, Foster City, CA) and used as previously described (Coats et al., 1996) . The oligonucleotides were added to the lovastatin-synchronized cells after release into the cell cycle at a concentration of 20 nM with 1.5 g/ml Cytofectin GS (Glen Research, Stering, VA).
FN Substrates
FN (Collaborative Biomedical Products, Bedford, MA) molecular coating densities were varied from ϳ50 to 3000 ng/cm 2 on bacteriological plastic (100-mm Petri dishes; Falcon, Lincoln Park, NJ) or glass slides (Lab-Tek, Nalge Nunc, Naperville, IL) using a carbonate buffer coating technique as previously described (Ingber, 1990) . Dishes were washed twice with PBS and blocked with 1% bovine serum albumin (Fraction V; Intergen, Purchase, NY) in basal medium (EBM; Clonetics) for 1 h at 37°C before plating. Higher cell plating numbers were used on low FN densities (2 ϫ 10 4 vs. 1 ϫ 10 4 cells/cm 2 on low vs. high FN, respectively). Adhesive islands with defined size, shape, and position on the micrometer scale were created on glass slides or silicon wafers (8 cm diameter) using a self-assembly-based micropatterning technique and coated with high-density FN, as described (Chen et al., 1997) . Cells were plated sparsely (3 ϫ 10 3 cells/cm 2 ) onto the adhesive islands to ensure that individual islands were seeded with single cells; this was confirmed using phase contrast microscopy in cells on glass slides and epifluorescence microscopy with cells labeled with 5 M CellTracker Green (5-chloromethylfluorescein diacetate) (Molecular Probes, Eugene, OR) on silicon wafers. F-actin was visualized in paraformaldehyde-fixed cells using FITC-conjugated phalloidin (300 ng/ml; Sigma).
Cell Cycle Analysis
The ability of CE cells to enter S phase was measured by quantitating the percentage of cells that exhibited nuclear incorporation of 5-bromo-2Ј-deoxyuridine (BrdU), as detected using a commercial assay (Amersham, Arlington Heights, IL). BrdU-positive fluorescent cells were visualized and scored using a Zeiss epifluorescence microscope with oil-immersion 40ϫ objectives (Carl Zeiss, Thornwood, NY); all nuclei were counterstained with the DNA-binding dye DAPI (1 g/ml). At least 12 random fields with a total of Ͼ500 cells were counted per sample.
The extent of pRb hyperphosphorylation was measured directly in Western blots (Buchkovich et al., 1989; DeCaprio et al., 1989) or indirectly using an in situ nuclear labeling technique (Mittnacht and Weinberg, 1991; Latham et al., 1996) . The in situ technique was based on the finding that hyperphosphorylated pRb easily dissociates from nuclei when treated with a nuclear extraction buffer (Mittnacht and Weinberg, 1991) . In brief, CE cells were washed once in PBS after 18 h of culture, incubated in nuclear extraction buffer (10 mM HEPES-KOH, pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.1% Triton X-100, 1 mM dithiothreitol) for 15 min at room temperature, fixed for 20 min in 4% paraformaldehyde/PBS, and washed with 0.1% bovine serum albumin/PBS. pRb was visualized by indirect immunostaining using anti-human pRb antibody LM95.1 (2 g/ml; Calbiochem); cells were also counterstained with DAPI to facilitate quantitation of the percentage of pRb-negative nuclei. Negative pRb staining indicated cells that contained hyperphosphorylated pRb that dissociated from nuclear matrix and hence, cells that successfully passed through the late G1 restriction point (Mittnacht and Weinberg, 1991; Latham et al., 1996) .
Reverse transcription (RT)-PCR was used to semiquantitatively analyze the expression of cell cycle-associated mRNAs in CE cells. Adherent CE cells were lysed, and total RNA was isolated using the RNeasy RNA extraction kit (Qiagen, Santa Clarita, CA). RNA (1 g/sample) was treated for 1 h at 37°C with RNase-free DNase I (0.8 U/ml; Boehringer Mannheim, Indianapolis, IN). The enzyme was then heat inactivated by boiling, and cDNA synthesis was carried out by incubating for 1 h at 45°C in 50 l buffer containing 50 mM Tris HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 1 mM dithiothreitol, 40 U rRNasin-RNase inhibitor (Promega, Madison, WI), 0.25 g/ml random hexamer (Boehringer Mannheim), a 0.5 mM final concentration of each dNTP, and 400 U Moloney murine leukemia virus reverse transcriptase (Life Technologies, Gaithersburg, MD). One microliter of reverse transcription product, or 1:3, 1:9, and 1:27, dilutions were used for PCR in a total volume of 25 l, containing 10 pmol of each primer, 0.2 mM of each dNTP, and 1 U of Taq polymerase enzyme (Boehringer Mannheim) in PCR reaction buffer provided by the manufacturer. PCR cycling conditions were 1 min at 94°C; then 24, 28, 32, and 36 cycles of 30 s at 94°C; 30 s at 56 -64°C; and 1 min at 72°C. For each dilution of cDNA template, products were analyzed at the different numbers of cycles to determine conditions of log-linear (slope ϭ 1) amplification permitting relative quantitation (Raeymaekers, 1995) . PCR products were separated by gel electrophoresis, stained with SybrGreen I (Molecular Probes), and visualized and quantitated in a FluorImager scanner (Molecular Dynamics, Sunnydale, CA). Primers were designed from GenBank sequences with Oligo 4.0 software (National Biosciences, Plymouth, MN) and synthesized by Genosys (Biotechnologies Industries, The Woodlands, TX).
For analysis of cell cycle-associated proteins, adherent CE cells were lysed in situ (0.5 ml lysis buffer/100-mm dish) as previously described (Latham et al., 1996) ; lysates from three micropatterned dishes were pooled and concentrated with a Biomax 5K centrifugal filter (Milipore, Bedford, MA). For Western blot analysis, protein lysates (10 g protein) were subjected to SDS-PAGE in 1.5-mm-thick minigels and transferred to a TransBlot (Bio-Rad, Hercules, CA) nitrocellulose membrane and immunoblotted with specific primary antibodies that were detected using horseradish peroxidase-conjugated secondary antibodies (Vector Laboratories, Burlingame, CA) and SuperSignal Ultra (Pierce, Rockford, IL) as a chemiluminescence substrate. Equal protein loading was confirmed by staining the membranes for total protein with India ink (1:1000) and by probing with antibodies to ␤-actin. Rabbit polyclonal antibodies to p44/p42 MAPK and activated (phosphorylated) p44/p42 MAPK were obtained from New England Biolabs (Beverly, MA). Monoclonal antibodies directed against pRb (LM95.1), cyclin E (HE12), and cyclin D3 (DCS-22) were from Calbiochem; against cyclin D1 (G124 -326) from PharMingen (San Diego, CA); and against p27 Kip1 (clone 57) and cdk2 (clone 55) from Transduction Laboratories (Lexington, KY). The monoclonal antibody against p21
Cip1 was generously provided by Ed Harlow (Harvard Medical School).
cell cycle by interfering with mevalonate synthesis (Keyomarsi et al., 1991) . Cells were released from the lovastatin block by addition of mevalonate, trypsinized, and immediately replated on dishes coated with a high density of FN (Ͼ1 g/cm 2 ), which supports optimal CE cell spreading ( Figure  1A ) and growth ( Figure 2A ). Under these conditions, the CE cells synchronously passed through the G1 restriction point at ϳ12 h after plating, as measured by hyperphosphorylation of the pRb (Figure 2B) , and entered S phase about 8 h later at ϳ20 h ( Figure 2D ).
To control the extent of cell spreading, lovastatinsynchronized CE cells were plated on dishes coated with varying densities of FN. As previously shown for bovine CE cells (Ingber, 1990) , decreasing the FN density from Ͼ1 g/cm 2 to Ͻ50 ng/cm 2 progressively restricted cell spreading (Figure 1 , B vs. A). Importantly, lowering the FN density also inhibited both pRb hyperphosphorylation ( Figure 2 , B and C) and incorporation of BrdU into DNA (Figure 2A ), even though cells were cultured in the presence of saturating concentrations of growth factors (5 ng/ml bFGF and 10 ng/ml EGF) as well as 2% serum. The lack of growth response was not due to reduced viability, because no apoptosis was observed at these densities of FN and the round (poorly spread) cells reattached and actively reextended when replated on high FN. Furthermore, the reduction in growth in nonspread cells was due to a block, rather than to a delay, in G1 progression, because moderately retracted cells on an intermediate FN density (100 ng/cm 2 ) and extended cells on high FN (3 g/cm 2 ) exhibited similar kinetics of S phase entry ( Figure 2E ). Cells on low FN (25 ng/cm 2 ) also never underwent pRb hyperphosphorylation, even at late times ( Figure 2B ). Varying the FN molecular coating density alters local integrin receptor clustering densities and associated intracellular integrin signaling activities as well as cell spreading Schwartz et al., 1991; McNamee et al., 1996) . Thus, it is not possible to discriminate between the effects of shape from those elicited by direct integrin receptor signaling using this model. To vary cell distortion and spreading while providing optimal integrin clustering locally, we cultured CE cells on adhesive islands of defined size and shape that were created using a self-assembly-based micropatterning technique and coated with a high density of FN (Singhvi et al., 1994; Chen et al., 1997) . Each adhesive island was separated from its neighbors by a nonadhesive barrier region that does not support FN adsorption and thus, does not promote cell anchorage or spreading. When synchronized CE cells were plated on these substrates, they selectively adhered to the FN-coated adhesive islands, exerted cytoskeletal tension on their matrix adhesions, and spread out until they reached the nonadhesive boundary. This resulted in cells that changed shape to fit the size (e.g., large or small) and form (round or square) of the island on which they adhered (Figure 1 , D, G, E, and H) as well as corresponding changes in F-actin organization and nuclear size (Figure 3 ). Diminishing the size (edge length) of the adhesive square from 80 to 30 m also dramatically lowered the fraction of cells Shape-dependent Growth Control Vol. 9, November 1998that exhibited pRb hyperphosphorylation and underwent DNA synthesis ( Figure 4A ). As with the reduction of FN density, decreasing the size of the adhesive island and preventing cell spreading reduced the transitional probability of entry into S phase but did not affect the length of G1 ( Figure 4B ). Interestingly, in situ analysis of pRb hyperphosphorylation revealed that when multiple cells adhered to a single adhesive island (80 m) and were locally restricted in their spreading, they behaved like cells on smaller islands and failed to hyperphosphorylate pRb, as indicated by retention of the hypophosphorylated form of pRb within the nucleus (Figure 3 , bottom right).
To further clarify that cell shape per se and not changes in the area of cell-matrix contacts was the critical factor, we plated CE cells on micropatterned substrates that contained multiple smaller, circular adhesive islands (5 m diameter) that were of the size Figure 3 . Control of cell shape, cytoskeletal organization, nuclear size, and pRB hyperphosphorylation on micropatterned adhesive islands. Shown are fluorescence views of CE cells cultured on square adhesive islands 30, 60, or 80 m wide and stained for F-actin using FITC-phalloidin, nuclei using the DNA binding dye DAPI, or nuclear-associated (hypophosphorylated) pRb using a monoclonal antibody. A rare occurrence can be seen at the bottom right, in which three cells are adherent to a single 80-m-wide island; note that these three smaller cells retain the hypophosphorylated form of pRB in their nuclei, whereas the single cell that is fully spread on the adjacent island at the left lacks nuclear pRB staining and hence, underwent pRb hyperphosphorylation. Figure 2D . of individual focal adhesions, separated by nonadhesive regions ( Figure 1I ). Under these conditions, single cells could now spread across multiple islands ( Figure  1F ), despite maintaining the total amount of cell-ECM contact area at a low level, equivalent to that exhibited by small 30-m squares that prevented growth (Figure 1, E and H) . The total area of cell-ECM contact on these dotted patterns was ϳ10-fold less than that achieved by cells that exhibited unrestricted spreading on an unpatterned substrate of identical chemistry (Chen et al., 1997) . Nevertheless, the spread cells on these dotted patterns exhibited high levels of pRb hyperphosphorylation and S phase entry ( Figure 4A ), similar to those observed in cells on the unrestricted substrates. Thus, these results show that cell shape or changes in cytoskeletal structure play a key role in the control of G1 progression during the CE cell cycle.
Shape-dependent Cell Cycle Arrest at the G1/S Transition
To narrow down the time window during G1 in which cell shape exerts its growth-regulatory effects, we first measured the activation of mitogen-activated protein kinases/extracellular signal-regulated kinases (MAPKs/ ERKs) p44/p42 MAPK (ERK1 and ERK2), which are activated by both mitogens (Anderson et al., 1990; Meloche et al., 1992) , and adhesion to the ECM (Chen et al., 1994; Morino et al., 1995, Zhu and Assoian, 1995) . These kinases exhibit a biphasic response including both rapid and delayed phases of activation that can be detected by measuring p44/p42 MAPK phosphorylation (Anderson et al., 1990) . The second, sustained phase of activation is thought to be essential for cell cycle progression to S phase (Meloche et al., 1992; Weber et al., 1997b) . When we measured p44/p42 MAPK activation in poorly spread CE cells on low FN and in highly extended cells on high FN 3 h after plating, we observed similar levels of p44/ p42 MAPK activation that progressively increased over a period of Ͼ6 h ( Figure 5A ). The finding that round and spread cells exhibited similar responses indicates that round cells did not fail to progress through G1 because of a block in the p44/p42 MAPK mitogenic signaling pathway. These studies also demonstrate that activation of the MAPK/ERK pathway is not sufficient to promote growth in these cells.
Cell cycle progression from G0/G1 to S phase is characterized by a series of transcriptional events involving expression of key cell cycle-related genes (Sherr, 1996) . Analysis of steady-state mRNA levels in synchronized CE cells replated on high versus low FN using semiquantitative RT-PCR revealed that expression of cyclin D1 and D3 mRNAs, two markers of early G1 progression, were not significantly different in round or spread cells when normalized to mRNA levels for the housekeeping gene ␤2-microglobulin ( Figure 5B ). The up-regulation of cyclin D1 mRNA in nonspread cells is indicative of induction of an early mitogenic response, possibly driven through the activation of p44/p42 MAPK (Lavoie et al., 1996) . In contrast, mRNAs for genes that are commonly expressed late in G1, including cyclin E and E2F-1 (Lew et al., 1991; Shan et al., 1992) , were only induced in spread cells on high FN ( Figure 5B ). The increase in expression of these genes at the G1/S border is thought to be induced by release of the transcription factor E2F-1 from its binding complex with pRb when pRb becomes hyperphosphorylated and inactivated (Nevins et al., 1997) . Thus, the profile of mRNA levels in retracted CE cells on low FN is consistent with a cell cycle block after mid G1, but before the point of pRb inactivation in late G1.
Shape-dependent Control of Cyclin D1 and p27
Kip1
To study the behavior of cyclins, cdks, and cdk inhibitors in shape-dependent growth control, we mea- 
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Vol. 9, November 1998sured levels of these critical regulatory proteins in total cell lysates. Western blot analysis revealed that spread cells on high FN and round cells on low FN had comparable levels of cdk2 and cdk4 as well as levels of cyclin D3 and cyclin E protein that remained relatively constant independent of where the cell was in the cell cycle ( Figure 6A ). In contrast, cyclin D1 protein levels increased ϳ3-fold in spread cells as the cells progressed to late G1, whereas only low basal levels of cyclin D1 were observed in round cells at similar times ( Figure 6A ). The cdk inhibitor p21 Cip1 did not appear to play an important role in shapedependent growth arrest, because p21
Cip1 levels were nearly identical in both spread and round cells. On the other hand, another cdk inhibitor, p27
Kip1 , appeared to play a key role in this response. Specifically, p27 Kip1 protein levels that were initially high after the lovastatin block decreased by more than fivefold as cells spread on high FN and progressed through G1. In contrast, round cells on low FN failed to down-regulate p27
Kip1 protein levels, and even accumulated p27
Kip1 in late G1 ( Figure 6A ). Thus, these results suggest that cell shape may regulate the G1/S transition by modulating expression of cyclin D1 and p27 Kip1 . To confirm that cell shape, rather than integrin binding and associated early signaling events, is responsible for control of p27
Kip1 levels, we carried out similar studies using cells cultured on micropatterned substrates. When cell spreading was restricted independently of ECM binding by culturing cells on small (30 m) adhesive islands ( Figure 1 , E and H), a dramatic accumulation of p27
Kip1 protein was observed in late G1 that was even more pronounced than that seen in cells on low FN ( Figure 6B ). Furthermore, cells that extended across multiple small adhesive islands (Figure 1, F 
and I; 5-m dots) down-regulated p27
Kip1 and thus behaved like spread cells on high FN density or on an unpatterned substrate, even though the total cell-ECM contact area was low ( Figure 6B ). Thus, expression of p27 Kip1 and passage through the G1/S transition appear to be sensitive to control by cell deformation, independent of the total area of cellmatrix contact formation.
To determine whether the observed changes in p27
Kip1 contributed to the shape-dependent cell cycle arrest, we transfected (Coats et al., 1996) lovastatinsynchronized CE cells with antisense oligonucleotides to p27
Kip1 upon plating onto high and low FN substrata. After 18 h, antisense-treated cells on low FN exhibited low levels of p27
Kip1 comparable with the spread cells on high FN. Although the anti-p27 Kip1 antisense treatment did not completely restore normal levels of cell cycle progression (50% nuclei labeled with BrdU), the percentage of round cells on low FN that incorporated BrdU and entered S phase increased by almost twofold (12-22%; p ϭ 0.0002). Thus, the high levels of p27 Kip1 induced by cell rounding appeared to contribute significantly to shape-dependent control of G1 progression in CE cells.
Role of the Actin Cytoskeleton and Mechanical Tension in Growth Control
Past studies in bovine CE cells and other cell types have shown that an intact cytoskeleton is required for progression through late G1 and entry into S phase Iwig et al., 1995; Bohmer et al., 1996). To determine whether the cytoskeleton is involved in shape-dependent control of cell cycle progression in human CE cells, we cultured cells on high FN and added the drug cyto D (1 g/ml) to disrupt actin network integrity at different time points after release from the lovastatin block. Cyto D caused cells to round up and arborize within 1 h after addition, although cells remained adherent to the FN substrate ( Figure 1C) . Addition of cyto D before the G1/S transition (10 h after removal of the lovastatin block), almost completely prevented pRb hyperphosphorylation and S phase entry (Figure 7) . When cyto D was added at 12 or 14 h (i.e., after pRb hyperphosphorylation was initiated), it became progressively less effective at decreasing the fraction of cells that underwent pRb hyperphosphorylation and entered S phase ( Figure 7A ). In contrast, when the actin cytoskeleton was disrupted at 18 h, after the onset of pRb hyperphosphorylation but before S phase initiation, no significant inhibition of cell cycle progression was observed and S phase entry proceeded normally ( Figure  7A ). Similar results were also obtained with latrunculin B (lat B), which disrupts the actin network by an entirely different mechanism (i.e., depolymerization of F-actin rather than loss of actin lattice continuity; Spector et al., 1989) (Figure 7B ). Interestingly, disruption of the actin cytoskeleton by cyto D at 10 h also led to accumulation of the cell cycle inhibitor p27
Kip1 whereas addition at 16 h in late G1 again had no effect ( Figure 6B ). These data demonstrate that cell spreading and an intact cytoskeleton act at the same point in the cell cycle to inhibit G1 progression and thus apparently harness the same molecular machinery to regulate growth in CE cells.
Although these and past studies with cytochalasins show that an intact cytoskeleton is required for cell cycle progression, the physiological relevance of "intactness" remains unclear. One possibility is that the effects of cell shape on growth may be mediated through changes in the cellular mechanical force balance (Ingber and Jamieson, 1985; Ingber, 1993; Chicurel et al., 1998a) . Because immobilized ECM molecules physically resist cell-generated tractional forces, levels of mechanical stress increase in the cytoskeleton in highly spread cells (Lee et al., 1998) ; these forces drive cytoskeletal restructuring inside the cell (Ingber, 1993; Chrzanowska-Wodnicka and Burridge, 1996) . This rise in internal cytoskeletal tension could convey regulatory signals to the cell, because externally applied mechanical stresses have been shown to regulate the growth of many cells (Ingber and Jamieson, 1985; Chicurel et al., 1998a) . To explore this possibility, an inhibitor of the myosin ATPase, 2,3-butanedione 2-monoxime (BDM), which interferes with actomyosin-based cytoskeletal tension generation (Chrzanowska-Wodnicka and Burridge, 1996) , was added to the synchronized, spread cells at different time points after plating. Similar to the effects produced by cyto D and lat B, addition of BDM before the onset of pRb phosphorylation (12-14 h) strongly inhibited entry into S phase, whereas addition at later times (16 -18 h) had no significant effect on S phase entry ( Figure 7B ). Importantly, these effects were induced without altering cell shape. Thus, the importance of an "intact" cytoskeleton for G1 progression may be due to its ability to generate mechanical tension and change the cellular mechanical force balance. 
DISCUSSION
The present studies were carried out to analyze how cell adhesion to ECM regulates cell cycle progression in CE cells. This is an important question because local changes in cell-ECM interactions and ECM mechanics govern whether individual CE cells will grow, differentiate, or die in response to stimulation by soluble mitogens in the tissue microenvironment during angiogenesis in vivo as well as in vitro (Ingber et al., 1986; Ingber and Folkman, 1989a,b; Ingber, 1990; Brooks et al., 1994; Re et al., 1994; Chen et al., 1997) . The establishment of local growth differentials is key to pattern formation in all developing tissues (Ingber and Jamieson, 1985) . Thus, elucidation of the mechanism by which ECM exerts this form of local growth control in CE cells could have important implications for other forms of morphogenesis as well.
It is well established that binding of ECM to cell surface integrin receptors can induce early signaling cascades and gene expression indicative of passage through the G0/G1 transition (Schwartz et al., 1991; McNamee et al., 1993, Vuori and Ruoslahti, 1993; Chen et al., 1994; Schlaepfer et al., 1994; Dike et al., 1996; Malik and Parson, 1996) . However, our results combined with those from past studies (Ingber, 1990; Chen et al., 1997) confirm that although these rapid and transient signals may be necessary, they are not sufficient for cell proliferation. In normal anchorage-dependent cells, cells must be continuously stimulated by both growth factor and ECM signals to pass through the late G1 restriction point that gates entry into S phase (Pardee, 1989; Assoian and Zhu, 1997) . Our results suggest that the signals provided by ECM that control passage through this G1/S transition in CE cells include both early chemical signals and equally important mechanical signals associated with cytoskeletal tension generation, physical distortion of the actin cytoskeleton, and associated cell spreading. Specifically, we found that lovastatin-synchronized CE cells effectively progressed through mid G1 phase, as evidenced by activation of p42/p44 MAPK and induction of cyclin D1 mRNAs, when stimulated by growth factors (bFGF and EGF) and serum regardless of whether the cells were spread or retracted on different FN densities. However, only the spread cells progressed through the G1/S transition, as indicated by pRb hyperphosphorylation, induction of expression of cyclin E and E2F-1 mRNAs, and incorporation of BrdU into DNA. This suggests that cell extension represents another distinct mitogenic stimulus whose persistence throughout G1 is required for entry into S phase.
Increasing the FN molecular coating density on otherwise nonadhesive dishes also promotes local integrin clustering and associated intracellular signaling events in addition to cell spreading McNamee et al., 1996) . Thus, we could not discriminate between these two potential regulatory influences using this technique alone. Importantly, use of micropatterned subtrates with defined chemistry and optimal (high) FN coating density allowed us to vary cell form independently of the FN density or the total area of cell-ECM contact formation. Moreover, by taking an adhesive area equal to a single small adhesive island that prevents spreading and growth and breaking it up into many smaller dispersed adhesive islands that promoted cell extension, we could promote S phase entry (Figure 4) . In other words, integrin-mediated changes in cell shape or spreading, rather than the local density of FN molecules beneath the cell or the total amount of cell-ECM contact area, was the critical determinant of whether CE cells would pass through the G1/S transition. These results suggest that cell binding to integrins provides two distinct growth signals to cells that are required for cell cycle progression: 1) early biochemical signals that are required for the G0-G1 transition, and 2) later mechanical signals that drive cytoskeletal restructuring and cell spreading and thereby dictate whether cells will pass through the late G1 transition and enter S phase.
Many past studies have shown that anchorage-dependent cells, such as CE cells, must spread to grow (Folkman and Moscona, 1978; Ben Ze'ev et al., 1980; Ingber, 1990; Chen et al., 1997) and that transformed cells lose this form of structural control (Wittelsberger et al., 1981) . However, the molecular basis for shapedependent growth control remains obscure. Our findings demonstrate that cell shape exerts its control over growth by harnessing the molecular machinery that cells normally use to control the G1/S transition. Cell spreading up-regulates cyclin D1 protein levels and decreases levels of the cdk inhibitor p27
Kip1 . Cyclin D1 acts as a sensor of extracellular mitogenic signals and plays a critical, rate-limiting role in cell cycle progression during mid G1 by initiating the multistep process that leads to pRb inactivation (Baldin et al., 1993; Quelle et al., 1993; Weinberg, 1995) . p27
Kip1 acts as a negative regulator of cyclin and cdk activity and appears to be both essential and sufficient to arrest cells before the late G1 restriction point Toyoshima and Hunter, 1994; Coats et al., 1996) . The effects of CE cell adhesion and spreading on these critical cell cycle regulators appeared to be specific, because levels of cyclin D3 protein and another cdk inhibitor, p21
Cip1 , remained unchanged under the same experimental conditions. We cannot distinguish to what extent targeted proteolysis (Alessandrini et al., 1997) or translational regulation (Hengst and Reed, 1996; Millard et al., 1997) are responsible for these effects on p27 Kip1 . However, past studies have shown that altering cell shape can regulate cytoplasmic tubulin levels by modifying protein degradation rates in-dependently of mRNA levels (Mooney et al., 1995) . Interestingly, cyclin D1 protein levels also appeared to be regulated posttranscriptionally by cell shape, because mRNA levels for cyclin D1 were not significantly different in cells on high versus low FN. This discrepancy might be due to changes in nuclear export of cyclin D1 mRNA or altered translational control (Rousseau et al., 1996; Zhu et al., 1996) , which itself could depend on cell spreading or associated changes in the transfer of mechanical forces across cell surface integrin receptors to ribosomes (Chicurel et al., 1998b) . Decreased levels of both cyclin D1 mRNA and protein have been seen in some past studies analyzing detached (round) versus adherent (spread) fibroblasts 1996 , Zhu et al., 1996 but not in others (Carstens et al., 1996; Fang et al., 1996; Kang and Krauss, 1996; Schulze et al., 1996) . The observed disparity between the induction of cyclin E mRNA and absence of changes in cyclin E protein levels (Figures 5B and 6A) remains unexplained but has been reported elsewhere (Herrera et al., 1996) .
The accumulation of p27 Kip1 in cells prevented from spreading suggests that this cdk inhibitor could play a role in the shape-dependent cell cycle arrest produced by cell rounding. p27
Kip1 has been similarly implicated in the cell cycle arrest caused by many other external factors, including transforming growth factor-␤ (Koff et al., 1993) , cell confluence , cAMP (Kato et al., 1994) , rapamycin (Nourse et al., 1994) , serum withdrawal (Coats et al., 1996) and lovastatin (Hengst and Reed, 1996) . Furthermore, increased levels of p27
Kip1 and p21 Cip1 have been observed in vascular smooth muscle cells that were growth arrested by plating on fibrillar (as opposed to monomeric) collagen substrates, which similarly suppress spreading of these cells (Koyama et al., 1996) . Increased levels of cdk inhibitors (both p27
Kip1 and p21
Cip1
) also appear to mediate the cell cycle arrest that is produced by placing fibroblasts in suspension (i.e., inhibiting substrate attachment) in some studies (Fang et al., 1996; Schulze et al., 1996; Zhu et al., 1996) but not in others (Kang and Krauss, 1996; Carstens et al., 1996) . Our results suggest that in CE cells, cell shape rather than anchorage per se may be the key regulator of p27 Kip1 . Furthermore, cyclin D and cdk4 -6 complexes have been proposed to promote cell cycle progression by binding and thereby sequestering p27
Kip1 from cyclin E and cdk2 complexes (Sherr and Roberts, 1995) . Therefore, in the present study, the inhibition of pRb hyperphosphorylation in retracted CE cells might be achieved by the combined effect of the reduction of cyclin D1 proteins, which would lead to a redistribution of sequestered p27
Kip1 to cdk2 complexes, together with the increased total levels of p27 Kip1 . Despite the pronounced cell shape-dependent upregulation of p27
Kip1 levels and the documented causal relation between p27
Kip1 and cell cycle arrest Toyoshima and Hunter, 1994; Coats et al., 1996) , it appears that shape-dependent arrest in primary human CE cells only partly depends on p27 Kip1 . When p27 Kip1 levels were lowered in round cells to levels comparable with spread cells using antisense oligonucleotides to p27 Kip1 , levels of S phase entry doubled; however, normal levels were not fully restored. The simplest explanation is that the basal cyclin D1 level in round cells ( Figure 6A) is not sufficient to drive G1 progression, even in the absence of high p27
Kip1 . This finding is also consistent with the report that p27
Kip1 -deficient mouse embryonal fibroblasts can still be induced to enter quiescence (Nakayama et al., 1996) . Together, these observations suggest that multiple pathways may contribute to this late G1 arrest in normal cells. Furthermore, in the case of our human CE cells cultured in the presence of optimal growth factors and ECM binding, p27
Kip1 appeared to contribute significantly to this regulatory mechanism and to mediate part of the effects of cell shape on cell cycle regulation.
It remains unclear how cell spreading down-regulates p27
Kip1 protein levels in CE cells. It has recently been reported that ectopic activation of the MAPK/ ERK pathway alone does not result in down-regulation of p27 Kip1 , although it induced expression of cyclin D1 (Rivard et al., 1996; Cheng et al., 1997) . Similarly, inhibition of the MAPK/ERK pathway did not affect p27
Kip1 down-regulation (Weber et al., 1997a) . These observations are consistent with our finding that p42/p44 MAPK is normally activated in retracted CE cells, which fail to down-regulate p27 Kip1 . The activation of p42/p44 MAPK in nonspread CE cells may seem to conflict with reports showing that integrin-mediated activation of the MAPK/ERK pathway can be inhibited by cyto D in fibroblasts (Chen et al., 1994; Morino et al., 1995; Clark and Hynes, 1996) . These reports, however, focused on the initial rapid phase of p42/p44 MAPK activation that occurs within minutes after integrin binding and thus before cell spreading is initiated. Actin disruption may therefore alter local biochemical events in the focal adhesions at these early times rather than cell spreading (Chen et al., 1994) . In contrast, Zhu and Assoian (1995) reported that integrin activation led to a gradual and persistent activation of p42/p44 MAPK rather than an immediate response, whereas Hotchin and Hall (1995) showed that binding to ECM in the absence of serum was not sufficient to activate p42/p44 MAPK . It is important to clarify that all of our studies were carried out in the presence of growth factors as well as ECM, whereas these past studies focused on activation of the MAPK/ ERK pathway by ECM alone. Our results therefore demonstrate that the activation of p42/p44 MAPK by combinations of growth factors and ECM occurs independently of cell spreading. At the same time, they show that activation of the MAPK/ERK pathway is not sufficient for growth in CE cells.
Taken together, these results suggest that cell cycle progression requires activation of distinct shape-dependent signaling cascades that act downstream or cooperatively with the MAPK/ERK pathway to shift the balance in the cyclin D1-p27
Kip1 control system and hence, promote transit through the G1/S restriction point. How can cell shape or spreading regulate the molecular machinery that is responsible for control of cell cycle progression? The mechanism and localization of the transduction of a geometric signal into a specific biochemical signal is poorly defined. Our results with cytoskeletal-disrupting agents, in conjunction with those from past studies Iwig et al., 1995; Bohmer et al., 1996) , suggest that changing cell shape alters growth signaling as a result of associated changes in the actin cytoskeleton. CE cells must maintain an intact actin cytoskeleton at the critical point in the late G1 phase of the cell cycle (10 -16 h after release from lovastatin arrest) when shape also exerts its critical regulatory control. Furthermore, both cell rounding and disruption of actin microfilament integrity with cyto D were found to exert this effect by up-regulating p27 Kip1 . Thus, adhesion-dependent changes in the cytoskeleton likely mediate the effects of ECM on the G1/S transition in CE cells.
Changes in cytoskeletal organization that mediate cell spreading are driven by mechanical tension that is generated within actomyosin filaments inside the cytoskeleton and transmitted across cell surface integrin receptors to the ECM substrate below (Ingber, 1993; Wang et al., 1993; Choquet et al., 1997; Chicurel et al., 1998b) . In other words, cells pull themselves outward and deform their cytoskeleton using their basal ECM as a mechanical resisting substrate. Our observation that G1 progression can be inhibited by preventing the development of isometric tension in the cytoskeleton using a myosin ATPase activity inhibitor supports the idea that growing cells may require an intact cytoskeleton to both generate mechanical tension and to respond to this force by restructuring itself. More importantly, our results suggest that it is this increase in isometric tension in the cytoskeleton and associated cytoskeletal restructuring events that leads to release of the G1 restriction in spread cells.
Recent studies confirm that altering the balance of mechanical forces transmitted between the cytoskeleton and ECM across integrins can regulate intracellular structure and biochemistry (Wang et al., 1993; Chen and Grinnell, 1995; Chicurel et al., 1998a,b; Schmidt et al., 1998) . Specific candidates for signaling pathway components that could link changes in mechanical forces transmitted across integrins with p27
Kip1 include the small-molecular-weight GTPase rho, which is involved in integrin-mediated changes in cytoskeletal tension and cell shape (Hotchin and Hall, 1995; Chrzanowska-Wodnicka and Burridge, 1996) . Importantly, rho activity recently has been shown to be essential for p27
Kip1 degradation in other cell types (Hirai et al., 1997; Weber et al., 1997a) . Another candidate is the integrin-linked kinase, which has been shown to reduce the inhibitory activity of p27
Kip1 and to promote anchorage-independent growth in other cell types (Radeva et al., 1997) .
Although signals elicited directly by binding of growth factors and ECM molecules to their respective cell surface receptors are necessary for initiating the growth process, they apparently are not sufficient to cause CE cell proliferation within the local tissue microenvironment (Ingber et al., 1986; Ingber and Folkman, 1989b) . Our results suggest that the changes in the balance of mechanical forces between integrins and the cytoskeleton that accompany cell spreading and drive cytoskeletal restructuring control downstream mitogenic signaling cascades and thereby govern the cellular response to other external stimuli. In other words, growth factors, ECM, and mechanical forces are all equally important biological regulators. This is a critical point because in living tissues, cells likely receive multiple simultaneous inputs, and yet an individual cell produces a single concerted response: it grows, becomes quiescent and differentiates, or dies locally. Early camera lucida studies of the mechanism of angiogenesis in vivo revealed that local changes in capillary growth and differentiation correlate with alterations in ECM mechanics (Clark and Clark, 1938) . A similar conclusion has been obtained from in vitro studies (Ingber and Folkman, 1989a,b; Vernon et al., 1992) . Thus, the local growth differentials that are responsible for creation of the branching patterns that define capillary networks during angiogenesis may result from the existence of this form of structural control whereby local mechanical stresses and distortion of molecular networks produce changes in intracellular biochemistry that control cell cycle progression.
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